Factors Determining the Liver Glycogenating Action of Orinase

1958 ◽  
Vol 192 (3) ◽  
pp. 514-516 ◽  
Author(s):  
W. L. Henry ◽  
John H. Kim ◽  
Alice S. Hall

The liver glycogenating action of Orinase was studied in normal, adrenalectomized and alloxan diabetic rats. The adrenalectomized rats were studied in three groups, salt maintained, cortisone maintained and cortisone plus adrenaline maintained. The alloxan diabetic rats were studied in two groups, protamine zinc insulin (P.Z.I.) maintained and uncontrolled. Of the adrenalectomized rats only those maintained on cortisone plus adrenaline responded to Orinase administration with increased liver glycogen. The alloxan diabetic animal maintained on P.Z.I. presented increased liver glycogen after Orinase administration but the untreated alloxan diabetic rat did not. This series of experiments indicated that the liver glycogenating effect seen during Orinase administration requires the participation of adrenomedullary, adrenocortical and beta cell hormones.

1977 ◽  
Vol 74 (2) ◽  
pp. 231-241 ◽  
Author(s):  
YVONNE MANGNALL ◽  
ANNE SMYTHE ◽  
D. N. SLATER ◽  
GILLIAN R. MILNER ◽  
R. D. G. MILNER ◽  
...  

Intraperitoneal transplantation of collagenase-digested, isogeneic, neonatal rat pancreatic tissue successfully reversed streptozotocin-induced diabetes in 77% of recipients. The low serum immunoreactive insulin, hyperglycaemia, glycosuria and weight loss, characteristic of the diabetic animal, were corrected and the reduced activities of hepatic glucokinase and pyruvate kinase, and the low glycogen concentration of the liver of diabetic rats were restored to normal. Forty-three per cent of the successfully transplanted rats became normoglycaemic within 1 month of transplantation whereas 57% took from 1 to 6 months to achieve normoglycaemia and displayed a mild glucose intolerance when subjected to a glucose load. The rats which had not become normoglycaemic 6 months after transplantation showed some amelioration of the diabetic state, as shown by increased serum immunoreactive insulin and hepatic glycogen concentration and a slow weight gain compared with diabetic controls.


1963 ◽  
Vol 41 (1) ◽  
pp. 2431-2439 ◽  
Author(s):  
G. Hetenyi Jr. ◽  
F. K. Kopstick ◽  
L. J. Retelstorf

In diabetic rats the concentration of glucose in the liver was less than in the plasma. The relative accumulation of glucose in the liver cell after the injection of insulin was also found to be significantly less in previously untreated diabetic than in normal rats. Pretreatment with insulin restored the response to normal. Experiments with labeled glucose indicated that the rate at which glucose is carried through the hepatic cell membrane is very high compared to the rate at which glucose is being formed in the liver cells in diabetic rats. The relatively small amount of glucose accumulating after insulin in livers of diabetic rats originates from the plasma. In adrenalectomized rats which have very little liver glycogen, the relative accumulation of glucose in liver cells, following the injection of insulin, was less than that in normals. These experiments indicate that in normal rats a large part of the glucose retained in the liver after the injection of insulin originates from non-labeled endogenous hepatic sources, presumably glycogen.


2016 ◽  
Vol 4 (1) ◽  
pp. 51-59 ◽  
Author(s):  
Talha Bin Emran ◽  
Mycal Dutta ◽  
Mir Muhammad Nasir Uddin ◽  
Aninda Kumar Nath ◽  
Md Zia Uddin

The study was designed to evaluate the glucose and cholesterol lowering effect of the aqueous extract of Centella asiatica leaf using the alloxan-induced diabetic rats and compared the activity with diabetic control and antidiabetic drug (Glibenclamide). Leaf extract (50 mg/kg) of C. asiatica and Glibenclamide were administered to normal and experimental diabetic rats for the duration of 10 days. In the alloxan-induced diabetic rat model, C. asiatica extract (50 mg/kg) significantly (p < 0.05) lowered the fasting blood glucose level as well as the total cholesterol level. Serum insulin levels were not stimulated in the animals treated with the extract. In addition, changes in body weight, serum lipid profiles and liver glycogen levels assessed in the extract treated diabetic rats were compared with diabetic control and normal animals. Significant results (p < 0.05) were observed in the estimated parameters. Surprisingly, body weight was increased significantly (p < 0.05) in the C. asiatica treated diabetic group. Phytochemical screening showed the presence of alkaloids, flavonoids, glycosides, steroids and tannins in significant amountsJahangirnagar University J. Biol. Sci. 4(1): 51-59, 2015 (June)


1957 ◽  
Vol 191 (2) ◽  
pp. 342-344
Author(s):  
L. L. Langley ◽  
C. H. Gunthorpe

The administration of 3 cc of adrenocortical extract (Upjohn) to adrenalectomized rats fasted at sea-level fails to cause liver glycogen deposition. Such animals under low atmospheric pressure accumulate about 1% liver glycogen. Adrenalectomized-hypophysectomized rats maintained on a minimal dose of hypophyseal extract, given 3 cc of adrenocortical extract and stressed do not deposit liver glycogen. These results suggest that the hypophyseal hormones function not only to control the adrenal cortices under these conditions, but also may contribute directly to the observed carbohydrate alterations. When larger doses of hypophyseal hormones are used there is a significant difference in liver glycogen between the stressed and nonstressed groups indicating the possible implication of still another agent, perhaps insulin, since alloxan diabetic rats do not accumulate liver glycogen in response to low atmospheric pressure.


1963 ◽  
Vol 41 (12) ◽  
pp. 2431-2439 ◽  
Author(s):  
G. Hetenyi Jr. ◽  
F. K. Kopstick ◽  
L. J. Retelstorf

In diabetic rats the concentration of glucose in the liver was less than in the plasma. The relative accumulation of glucose in the liver cell after the injection of insulin was also found to be significantly less in previously untreated diabetic than in normal rats. Pretreatment with insulin restored the response to normal. Experiments with labeled glucose indicated that the rate at which glucose is carried through the hepatic cell membrane is very high compared to the rate at which glucose is being formed in the liver cells in diabetic rats. The relatively small amount of glucose accumulating after insulin in livers of diabetic rats originates from the plasma. In adrenalectomized rats which have very little liver glycogen, the relative accumulation of glucose in liver cells, following the injection of insulin, was less than that in normals. These experiments indicate that in normal rats a large part of the glucose retained in the liver after the injection of insulin originates from non-labeled endogenous hepatic sources, presumably glycogen.


The apparent disappearance of sugar injected into normal animals has for a long time puzzled physiological investigators (Bang, Meltzer and Kleiner, Palmer, Woodyatt). When insulin was discovered it was apparent that an agent was available by which the normal processes could be exaggerated, and therefore more easily studied. It was soon shown that the administration of sugar and insulin to the diabetic animal resulted in an increased combustion of carbohydrate and the accumulation of glycogen in the depôts. When, however, attempts were made to trace the fate of the sugar which disappears from the blood of the normal animal under the influence of an injection of insulin, difficulties were encountered. McCormick and Macleod (1) studied the effect of insulin on the glycogen reserves of rabbits which had been starved and treated with epinephrin. In some of the experiments glucose was administered subcutaneously during the period of action of insulin. No significant difference between the glycogen content of the muscles of the control animals and of those which received insulin was observed. The glycogen of the livers of the insulin-treated animals was slightly less than that of the control animals. Macleod (2) concluded from these experiments “that less glycogen is deposited both in the muscles and the liver when insulin is given along with sugar to previously starved animals than when the same amounts of sugar are given alone.” In the experiments of Dudley and Marrian (3), in which the effect of insulin on the liver glycogen of mice was studied, a much smaller amount of glycogen was found in the livers of the animals which received insulin than in those which served for controls. In another series of experiments in which insulin was administered to rabbits which had been previously fed on a carbohydrate rich diet, the glycogen content of the liver and skeletal muscles of the insulin-treated animals was again much less than that of the control animals. In both series of experiments the animals were killed after convulsions had supervened. The experiments of Babkin (4) are similar to those of McCormick and Macleod. In some of his experiments Babkin kept the blood sugar of the rabbits at a high level by the administration of sugar. He found no increase in glycogen after insulin. Kuhn and Baur (5), in a study of the effect of insulin on the glycogen content of the skeletal muscles of rabbits and guinea-pigs, found that, after insulin convulsions, the glycogen had practically disappeared from the muscles of these animals. They are undecided as to whether the depletion of glycogen is a primary effect of insulin or is to be attributed to the convulsions.


2018 ◽  
Vol 21 (04) ◽  
pp. 717-722
Author(s):  
Muhammad Sajid Khan ◽  
Aneela Qureshi ◽  
Shuja Anwar Kazi ◽  
Amin Fahim ◽  
Husan Bano ◽  
...  

Objective: To evaluate the anti diabetic effect of cinnamon extract in alloxaninduced diabetic animal model (albino rats) in comparison with oral hypoglycemic drugs. StudyDesign: An Experimental study. Place of Study: Al Tibri Medical College, Isra University, KarachiCampus. Duration of Study: December 2012 to December 2013. Materials and Methods: Total60 Albino rats of both genders were divided into 6 groups consisting of 10 rats in each group.Each group of animals was further divided into two sub groups containing 5 rats in each groupResults: The results obtained from the data indicated that there is significant reduction in bloodglucose level rats treated with low dose of cinnamon extract. The animals of low dose cinnamonextract (200mg/kg. bw) when compared with other groups; there is a reduction in the bloodglucose level in alloxan induced diabetic rats. Also tolbutamide and acarbose treated groupsshowed better antidiabetic effects as compared with cinnamon extract treated groups (pvalue<0.007 and p value<0.012 respectively), but cinnamon extract treated group showedsynergetic effects when it was given in combination with tolbutamide or acarbose havingsignificant p value<0.001 and p value<0.011 respectively. Conclusions: Tolbutamide andAcarbose showed better anti diabetic effect in comparison with cinnamon extract treated groupswhen used individually. This effect was enhanced when cinnamon was used in combination witheither tolbutamide or acarbose.


2020 ◽  
Vol 11 ◽  
pp. 204173142092481
Author(s):  
Jordan Magisson ◽  
Aladin Sassi ◽  
Daela Xhema ◽  
Aram Kobalyan ◽  
Pierre Gianello ◽  
...  

Cell encapsulation could overcome limitations of free islets transplantation but is currently limited by inefficient cells immune protection and hypoxia. As a response to these challenges, we tested in vitro and in vivo the safety and efficacy of a new macroencapsulation device named MailPan®. Membranes of MailPan® device were tested in vitro in static conditions. Its bio-integration and level of oxygenation was assessed after implantation in non-diabetic rats. Immune protection properties were also assessed in rat with injection in the device of allogeneic islets with incompatible Major Histocompatibility Complex. Finally, function was assessed in diabetic rats with a Beta cell line injected in MailPan®. In vitro, membranes of the device showed high permeability to glucose, insulin, and rejected IgG. In rat, the device displayed good bio-integration, efficient vascularization, and satisfactory oxygenation (>5%), while positron emission tomography (PET)-scan and angiography also highlighted rapid exchanges between blood circulation and the MailPan®. The device showed its immune protection properties by preventing formation, by the rat recipient, of antibodies against encapsulated allogenic islets. Injection of a rat beta cell line into the device normalized fasting glycemia of diabetic rat with retrieval of viable cell clusters after 2 months. These data suggest that MailPan® constitutes a promising encapsulation device for widespread use of cell therapy for type 1 diabetes.


1982 ◽  
Vol 202 (2) ◽  
pp. 363-368 ◽  
Author(s):  
B R Odedra ◽  
S S Dalal ◽  
D J Millward

The effect of insulin infusion in vivo on muscle protein synthesis was investigated in rats. In 10-days-streptozotocin-diabetic rats infused in vivo with amino acids and glucose, the rate of protein synthesis per unit of RNA (RNA activity) was markedly decreased. Pre-treatment with large doses of insulin at 17 and 1 h before the infusion fully restored RNA activity to normal. Infusion of insulin for 6 h with amino acids and glucose did not restore RNA activity to normal in the diabetic rats. However, in diabetic-adrenalectomized rats similar infusions of insulin fully restored RNA activity to normal. Measurements of plasma corticosterone concentrations indicated a 50% increase in the diabetic rats. Since pre-treatment with corticosterone suppressed the stimulatory effect of insulin infusion on RNA activity in adrenalectomized rats, and since corticosterone treatment for 6 days suppressed RNA activity even though insulin concentrations were elevated, it is suggested that increased concentrations of corticosterone are responsible for the lag in response to insulin in the diabetic rat. This means that the catabolic effects of glucocorticoids must be also considered together with the catabolic effect of insulin lack in diabetes.


2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Saheem Ahmad ◽  
Mohd. Sajid Khan ◽  
Sultan Alouffi ◽  
Saif Khan ◽  
Mahvish Khan ◽  
...  

Proteins undergo glycation resulting in the generation of advanced glycation end products (AGEs) that play a central role in the onset and advancement of diabetes-associated secondary complications. Aminoguanidine (AG) acts as an antiglycating agent by inhibiting AGE generation by blocking reactive carbonyl species (RCS) like, methylglyoxal (MGO). Previous studies on antiglycating behavior of AG gave promising results in the treatment of diabetes-associated microvascular complications, but it was discontinued as it was found to be toxic at high concentrations (>10 mmol/L). The current article aims at glycation inhibition by conjugating gold nanoparticles (Gnp) with less concentration of AG (0.5-1.0 mmol/L). The HPLC results showed that AG-Gnp fairly hampers the formation of glycation adducts. Moreover, the in vivo studies revealed AG-Gnp mediated inhibition in the production of total-AGEs and - N ε -(carboxymethyl)lysine (CML) in the diabetic rat model. This inhibition was found to be directly correlated with the antioxidant parameters, blood glucose, insulin, and glycosylated hemoglobin levels. Furthermore, the histopathology of AG-Gnp-treated rats showed good recovery in the damaged pancreatic tissue as compared to diabetic rats. We propose that this approach might increase the efficacy of AG at relatively low concentrations to avoid toxicity and might facilitate to overcome the hazardous actions of antiglycating drugs.


Sign in / Sign up

Export Citation Format

Share Document